NANCY GIAIMO: Open Payments
NPI 1699719971 · LAKE ST LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 17 payments from 12 companies in 2025. Trend: 2023 $921 · 2024 $777 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $53 |
| ABBVIE INC. | 3 | $52 |
| Lilly USA, LLC | 2 | $34 |
| Medtronic, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: Ozempic, MOUNJARO, VRAYLAR, INCEPTIV, FANAPT, UBRELVY, GEMTESA, Jornay PM.
Industry payments across MO — which companies pay providers there.
